Literature DB >> 6866232

Solvent systems for intracarotid 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) infusion.

R L Ross, J P Kapp, F Hochberg, I S Krull, X D Ding, C Selavka.   

Abstract

The agent, 1,3-bis(3-chloroethyl)-1-nitrosourea (BCNU), when given by arterial infusion for brain tumor chemotherapy is usually dissolved in an alcohol/saline solution. The authors compared the osmolality of and drug recovery from solvent systems of alcohol/saline, dimethyl sulfoxide (DMSO)/water, and dextrose/water. Recovery of drug was adequate from all solvent systems, although variability of drug recovery from the alcohol/saline and DMSO/water systems was greater than from the dextrose/water system. The alcohol/saline system was significantly hyperosmolar. The alcohol/saline and DMSO/water solvent systems offer no advantage over the dextrose/water system and may be associated with significant disadvantages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6866232     DOI: 10.1227/00006123-198305000-00006

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  5 in total

1.  Supraophthalmic carotid infusion for recurrent glioma: rationale, technique, and preliminary results for cisplatin and BCNU.

Authors:  J P Kapp; R B Vance
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

2.  Intra-arterial BCNU in the treatment of metastatic brain tumors.

Authors:  T L Cascino; T N Byrne; M D Deck; J B Posner
Journal:  J Neurooncol       Date:  1983       Impact factor: 4.130

3.  BCNU stability as a function of ethanol concentration and temperature.

Authors:  P Tepe; S J Hassenbusch; R Benoit; J H Anderson
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

4.  Effect of intra-arterial cisplatin and 1,3-bis(2chloroethyl)-1-nitrosourea (BCNU) dosage on radiographic response and regional toxicity in malignant glioma patients: proposal of a new method of intra-arterial dosage calculation.

Authors:  H Bobo; J P Kapp; R Vance
Journal:  J Neurooncol       Date:  1992-07       Impact factor: 4.130

5.  Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.

Authors:  J Théron; J G Villemure; C Worthington; J L Tyler
Journal:  Neuroradiology       Date:  1986       Impact factor: 2.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.